HNI Stock Analysis: HNI | NYSE
Furnishings, Fixtures & Appliances | NYSE, USA | Market Cap: 3.547m USD | 12M Return: 28.5% | US4042511000 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.8M
EPS Trend: 92.2%
Qual. Beats: 2
Rev. Trend: 80.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
HNI Corporation is a U.S.-based manufacturer operating in two segments: Workplace Furnishings and Residential Building Products, with primary operations in the United States and Canada. Headquartered in Muscatine, Iowa, and incorporated in 1944, the company markets its products under a broad portfolio of well-known brands such as HON, Kimball, HBF, Allsteel, Coalesse, National, Gunlocke, and others. HNI is classified under the GICS Industrials sector, specifically within the Office Services & Supplies sub-industry, and competes in a market environment that includes large peers such as Steelcase and Haworth. The Workplace Furnishings segment sells panel-based and freestanding furniture systems, seating, tables, storage, and architectural products through independent dealers, company-owned dealers, office product distributors, and direct-to-customer and government channels. The Residential Building Products segment provides gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits, and accessories through independent dealers, distributors, and corporation-owned retail and installation outlets.
- Workplace Furnishings revenue tied to office return and corporate capex
- Residential Building Products demand pressured by higher mortgage rates
- Input cost inflation compresses margins across both segments
| Net Income: 53.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -11.78 > 1.0 |
| NWC/Revenue: 6.98% < 20% (prev 5.16%; Δ 1.82% < -1%) |
| CFO/TA 0.01 > 3% & CFO 68.9m > Net Income 53.1m |
| Net Debt (1.81b) to EBITDA (454.9m): 3.98 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.5m) vs 12m ago 55.25% < -2% |
| Gross Margin: 40.49% > 18% (prev 40.68%; Δ -0.20% > 0.5%) |
| Asset Turnover: 155.3% > 50% (prev 140.7%; Δ 14.56% > 0%) |
| Interest Coverage Ratio: 2.62 > 6 (EBIT TTM 211.4m / Interest Expense TTM 80.6m) |
| A: 0.07 (Total Current Assets 1.49b - Total Current Liabilities 1.12b) / Total Assets 4.99b |
| B: 0.12 (Retained Earnings 590.4m / Total Assets 4.99b) |
| C: 0.06 (EBIT TTM 211.4m / Avg Total Assets 3.41b) |
| D: 0.60 (Book Value of Equity 1.87b / Total Liabilities 3.11b) |
| Altman-Z'' = 1.92 = BBB |
| DSRI: 1.34 (Receivables 701.9m/255.6m, Revenue 5.30b/2.59b) |
| GMI: 1.00 (GM 40.68% / 40.49%) |
| AQI: 1.21 (AQ_t 0.44 / AQ_t-1 0.36) |
| SGI: 2.04 (Revenue 5.30b / 2.59b) |
| TATA: -0.00 (NI 53.1m - CFO 68.9m) / TA 4.99b) |
| Beneish M = -1.87 (Cap -4..+1) = B |
As of November 12, 2026, the stock is trading at USD 49.02 with a total of 400,090 shares traded. Over the past week, the price has changed by -0.24%, over one month by +3.66%, over three months by -0.31% and over the past year by +28.45%.
Current recommended Stop Loss: 45.80 (which is 6.6% or 1.8 ATR below the current price).
HNI has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy HNI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71 | 44.8% |
P/E Trailing = 163.8
P/E Forward = 10.5597
P/S = 0.6691
P/B = 1.9861
P/EG = 0.7038
Revenue TTM = 5.30b USD
EBIT TTM = 211.4m USD
EBITDA TTM = 454.9m USD
Long Term Debt = 1.28b USD (from longTermDebt, last fiscal year)
Short Term Debt = 99.9m USD (from shortTermDebt, last quarter)
Debt = 1.93b USD (from shortLongTermDebtTotal, last quarter) + Leases 268.9m
Net Debt = 1.81b USD (calculated: Debt 1.93b - CCE 114.0m)
Enterprise Value = 5.36b USD (3.55b + Debt 1.93b - CCE 114.0m)
Interest Coverage Ratio = 2.62 (Ebit TTM 211.4m / Interest Expense TTM 80.6m)
EV/FCF = -76.46x (Enterprise Value 5.36b / FCF TTM -70.1m)
FCF Yield = -1.31% (FCF TTM -70.1m / Enterprise Value 5.36b)
FCF Margin = -1.32% (FCF TTM -70.1m / Revenue TTM 5.30b)
Net Margin = 1.00% (Net Income TTM 53.1m / Revenue TTM 5.30b)
Gross Margin = 40.49% ((Revenue TTM 5.30b - Cost of Revenue TTM 3.15b) / Revenue TTM)
Gross Margin QoQ = 42.60% (prev 43.96%)
Tobins Q-Ratio = 1.08 (Enterprise Value 5.36b / Total Assets 4.99b)
Interest Expense / Debt = 4.18% (Interest Expense 80.6m / Debt 1.93b)
Taxrate = 40.54% (36.2m / 89.3m)
NOPAT = 125.7m (EBIT 211.4m * (1 - 40.54%))
Current Ratio = 1.33 (Total Current Assets 1.49b / Total Current Liabilities 1.12b)
Debt / Equity = 1.03 (Debt 1.93b / totalStockholderEquity, last quarter 1.87b)
Debt / EBITDA = 3.98 (Net Debt 1.81b / EBITDA 454.9m)
Debt / FCF = -25.86 (negative FCF - burning cash) (Net Debt 1.81b / FCF TTM -70.1m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.56% (Net Income 53.1m / Total Assets 4.99b)
RoE = 2.92% (Net Income TTM 53.1m / Total Stockholder Equity 1.82b)
RoCE = 6.82% (EBIT 211.4m / Capital Employed (Equity 1.82b + L.T.Debt 1.28b))
RoIC = 3.27% (NOPAT 125.7m / Invested Capital 3.85b)
WACC = 6.44% (E(3.55b)/V(5.47b) * Re(8.59%) + D(1.93b)/V(5.47b) * Rd(4.18%) * (1-Tc(0.41)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 81.65 | Cagr: 19.89%
[DCF] Fair Price = unknown (Cash Flow -70.1m)
EPS Correlation: 92.24 | EPS CAGR: 12.81% | SUE: 2.05 | # QB: 2
Revenue Correlation: 80.64 | Revenue CAGR: 25.66% | SUE: -0.12 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.53 | Chg30d=-4.55% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=4.22 | Chg30d=-0.88% | Revisions=-25% | GrowthEPS=+21.9% | GrowthRev=+110.7%
EPS next Year (2027-12-31): EPS=4.78 | Chg30d=-1.19% | Revisions=-40% | GrowthEPS=+13.3% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -57% (up=0, down=4)